Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. ( DrugBank: Teicoplanin )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
299嚢胞性線維症1

299. 嚢胞性線維症


臨床試験数 : 1,696 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04176328
(ClinicalTrials.gov)
October 25, 20198/11/2019Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis PatientsAn Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis PatientsCystic FibrosisDrug: Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.Neupharma SrlSintesi Research Srl;Aptuit Srl;Pari Pharma GmbHCompleted18 YearsN/AAll12Phase 1Italy